Английская Википедия:Efpeglenatide
Материал из Онлайн справочника
Efpeglenatide is a GLP-1 receptor agonist under development for the treatment of type 2 diabetes and obesity and reducing the risk of cardiovascular incidents in people with these conditions.[1][2][3][4][5][6][7] Its developer is Hanmi Pharmaceutical.[8]
References